Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists
Amanda H. Seipel(Karolinska Institutet), Lars Egevad(Karolinska Institutet), Isabell A. Sesterhenn(Latino Health Institute (United States)), David J. Grignon(Indiana University School of Medicine), Kiril Trpkov(University of Calgary), Samson W. Fine(Memorial Sloan Kettering Cancer Center), Brett Delahunt(Malaghan Institute of Medical Research), Cristina Magi‐Galluzzi(University of Alabama at Birmingham), Hemamali Samaratunga(The University of Queensland), Athanase Billis(Universidade Estadual de Campinas (UNICAMP)), Amar Ahmad(Cancer Research UK), Rodolfo Montironi(Marche Polytechnic University), Theodorus van der Kwast(Erasmus MC), Peter A. Humphrey(Jewish Hospital), Éva Compérat(Vienna General Hospital), Daniel M. Berney(Queen Mary University of London), Murali Varma(University Hospital of Wales), Liang Cheng(Brown University), Ming Zhou(Indiana University School of Medicine), Mahul B. Amin(Ontario Institute for Cancer Research), John R. Srigley(University of Toronto), Andrew Evans(University of Toronto), Sue Moss(Queen Mary University of London), Joel Barton
Cited by 51
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705